NEO Stock Analysis: Buy, Sell, or Hold?
NEO - NeoGenomics, Inc.
$9.02
0.41 (4.76%)
▲
5d:
+13.32%
30d:
+25.45%
90d:
-27.67%
HOLD
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: Apr 28, 2026
0d
Get Alerted When NEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: NEO is 7.1% above its trading range ($8.42). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: NEO is 7.1% above its trading range ($8.42). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$15.72
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$9.76
7.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NEO is currently trading at $9.02, which is considered extended relative to its 30-day fair value range of $7.63 to $8.42. From a valuation perspective, the stock is trading at a discount (Forward PE: 27.9) compared to its historical average (47.3). Remarkably, the market is currently pricing in an annual earnings decline of 16.1% over the next few years. This pessimistic expectation contrasts with the company's recent 130.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, NEO is in a strong downtrend. The price is approaching resistance at $8.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: NEO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.19 (+57.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NEO is in a strong downtrend. The price is approaching resistance at $8.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: NEO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.19 (+57.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.63 -
$8.42
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range (+7.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.8%)
- BULLISH: Trading 57.3% below Wall St target ($14.19)
- CAUTION: Extended 7.1% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$7.63 -
$8.42
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.69
Resistance Level
$8.80
Current Trend
Strong Downtrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.93
Wall Street Target
$14.19
(+57.3%)
Revenue Growth (YoY)
10.6%
Earnings Growth (YoY)
130.6%
Profit Margin
-14.8%
Valuation Discount vs History
-16.1% cheaper
PE vs Historical
27.9 vs 47.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.1%
(market-implied from PE analysis)
1-Year Target
$8.12
(-10%)
2-Year Target
$7.31
(-19%)
3-Year Target
$6.58
(-27%)
3-Yr Target (if PE normalizes)
(PE: 28→47)
$11.14
(+24%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.9, Growth: 108.4%)
$30.44
(+238%)
Base:
(SPY PE: 20.6, Growth: 108.4%)
$22.47
(+149%)
Bear:
(PE: 17.5, Growth: 108.4%)
$19.10
(+112%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.9 to 47.3
Stabilization Target:
$15.28
(+69.4%)
PE Expansion Potential:
+69.4%
Share & Embed Analysis
Last updated: April 29, 2026 6:59 AM ET
Data refreshes hourly during market hours. Next update: 7:59 AM
Data refreshes hourly during market hours. Next update: 7:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Warren Stone
SELL
22128 shares
2026-01-20
Alicia C Olivo
SELL
20916 shares
2025-11-25
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$623 | 58 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$250 | 56 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$128 | 57 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$258 | 56 HOLD |
